within Pharmacolibrary.Drugs.ATC.C;

model C07AA14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 1.1666666666666667,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.18,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mepindolol is a non-selective beta-adrenergic antagonist (beta-blocker) that was previously used for the treatment of hypertension and some cardiac arrhythmias. Its clinical use has declined and it is not commonly approved or available for therapy today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult; no direct published clinical PK data could be identified.</p><h4>References</h4><ol><li>W Krause, C Lennert,Pharmacokinetics of mepindolol administered alone and in combination with hydrochlorothiazide--a bioequivalence study.,Biopharmaceutics & drug disposition,1983<a href='https://pubmed.ncbi.nlm.nih.gov/6689277/'>https://pubmed.ncbi.nlm.nih.gov/6689277/</a></li><li>W Krause, G KÃ¼hne,Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.,Drug metabolism and disposition: the biological fate of chemicals,1983<a href='https://pubmed.ncbi.nlm.nih.gov/6133729/'>https://pubmed.ncbi.nlm.nih.gov/6133729/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AA14;
